Beti-cel gene therapy achieves high rates of transfusion independence in severe β-thalassemia
1. 89% of patients achieved transfusion independence with beti-cel gene therapy. 2. There were no serious adverse events or treatment-related ...
Tag: autologous stem cell transplantation
#VisualAbstract GIMEMMA-MMY-3006: Bortezomib, Thalidomide, and Dexamethasone (VTD) Followed By Stem-Cell Transplantation Improves Long-Term Survival Outcomes in Newly Diagnosed Multiple Myeloma (MM)
Check out the original article from the Lancet Haematology here.
Quick Take: Oral Ixazomib Maintenance Following Autologous Stem Cell Transplantation (TOURMALINE-MM3): A Double-Blind, Randomised, Placebo-Controlled Phase 3 Trial
Autologous stem cell transplantation (ASCT) is commonly used in the treatment of multiple myeloma, though relapse is extremely common. Ixazomib ...
Autologous stem-cell transplantation improves survival in scleroderma patients: The SCOT trial
1. Scleroderma patients treated with myeloablative autologous stem-cell transplantation experienced significantly higher rates of disease-free survival at 52 months post-treatment ...
Prophylactic letermovir significantly reduces cytomegalovirus infection after transplantation
1. Compared to placebo, letermovir prophylaxis significantly decreased the incidence of cytomegalovirus (CMV) infection through 24 weeks following hematopoietic stem ...
Autologous hematopoietic stem cell transplantation associated with long-term remission in myasthenia gravis
1. This retrospective cohort study examined seven patients with myasthenia gravis (MG) refractory to immunosuppressive therapy who underwent autologous hematopoietic ...
